Contract award · 25 Jun 2025

NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National

NHS England awarded “NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza…” to Accord-UK Ltd, Amgen Ltd, AstraZeneca for £262m on 25 Jun 2025.

Medical equipment & pharmaceuticalsNorth West

BuyerNHS England
Value £262m
WinnersAccord-UK Ltd SME, Amgen Ltd +26 more

Open competition

Open procedure: the contract was advertised and any supplier could submit a bid.

Key facts

Buyer
NHS England · Body governed by public law
Value
£261,895,933
Procedure
Open procedure (above threshold)
Sector
Medical equipment & pharmaceuticals · Pharmaceutical products (CPV 33600000)
Timeline
  1. Contract date25 Jun 2025
  2. Published24 Jul 2025Published 29 days after the contract date

Description

NHS Framework Agreement for Branded Medicines - Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 Offer reference number: CM/PHR/24/5718 CM/PHR/24/5718/01 - NHS Framework Agreement for Branded Medicines - Tranche A for London and South of England. Period of Framework Agreement: 01 September 2025 to 31 August 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/24/5718/02 - NHS Framework Agreement for Branded Medicines - Adult Influenza (National). Period of Framework Agreement: 01 September 2025 to 31 August 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 36 months.

About the suppliers

More from NHS England

All contracts

More won by Accord-UK Ltd

All contracts

Recent medical equipment & pharmaceuticals contracts

Sector overview